Anti-BSA antibodies are a major cause of non-specific binding in insulin autoantibody radiobinding assays

Addition of BSA to assay buffer improves the screening efficiency of the IAA assay without reducing disease sensitivity in patients. High titre BSA antibodies interfere with IAA measurement because of 125I-BSA present in some insulin labels. Improved purification of insulin labels should obviate the need for competitive displacement.